ANI Pharmaceuticals (NASDAQ:ANIP): Q4 Non-GAAP EPS of $1.08 misses by $0.10; GAAP EPS of -$0.41 misses by $0.56.
Revenue of $47.97M (-16.0% Y/Y) misses by $3.66M.
https://seekingalpha.com/news/3546481-ani-pharmaceuticals-eps-misses-0_10-misses-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.